Search Results 181-190 of 17203 for Hepatocyte
Mayo Clinic has a long history of important contributions to advances in the diagnosis and treatment of liver disease. Current efforts include studies of the ...
This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.
The Biospecimen and Pathology Core provides patient data, liver and biliary cancer tissue biospecimens, and patient-derived xenografts for the Hepatobiliary ...
This contagious liver infection can be long lasting. Learn how the infection spreads and what you can do to prevent or treat it.
The purpose of this study is evaluation of efruxifermin (EFX) in subjects with compensated cirrhosis due to NASH/MASH. This is a Phase 3, randomized, double- ...
This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.
The goal of the study is to identify immune responses (immune cell activation and suppression) following local ablation of liver tumors. Participation ...
The Developmental Research Program in the Mayo Clinic Hepatobiliary SPORE supports promising investigators working on innovative hepatobiliary cancer (liver ...
In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.